Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Multiple Myeloma 2Lymphoma 2Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Cancer Related Cognitive Difficulties 1

Interventions

Cyclophosphamide 23fludarabine 14Rituximab 14Specimen Handling 8Magnetic Resonance Spectroscopy 7Doxorubicin 7pirtobrutinib 6Vincristine 6Prednisone 6polatuzumab vedotin 5obinutuzumab 5zanubrutinib 4glofitamab 4Nivolumab 4Etoposide 4Dexamethasone 4Biopsy 4tazemetostat 3tafasitamab 3pembrolizumab 3ibrutinib 3fludarabine phosphate 3acalabrutinib 3Immunotherapy, Adoptive 3Bendamustine Hydrochloride 3venetoclax 2pomalidomide 2loncastuximab tesirine 2etoposide phosphate 2cemiplimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, B-Cell × Neuropsychological Tests × 90 days × Clear all
NCT04300998 2026-04-07

Study of CAR-T Therapy in Older Patients

Memorial Sloan Kettering Cancer Center

Recruiting
154 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡